Skip to main content

Table 3 The survival analysis of the effect of clinical pathological characteristics on prognosis in ovarian carcinoma

From: FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma

Parameter Relapse P value a P value b DOD P value c P value d
 +   + 
Age
 < 57 24 28 0.172 17 41 0.240
 ≥ 57 37 26 26 41
FIGO staging system
 I–II 9 34  < 0.001  < 0.001 6 37 0.002 0.1
 III–IV 52 20 37 45
Lymphatic metastasis
 No 31 43 0.001 0.595 23 53 0.169
 Yes 29 10 20 27
HDAC3 H-score
 Low expreesion 19 40  < 0.001 0.008 9 52  < 0.001  < 0.001
 High expression 42 14 34 30
FOXA1 H-score
 Low expression 23 35 0.001 0.853 14 46 0.006 0.951
 High expression 38 19 29 36
  1. DOD  death due to disease, cm centimeter, LNM lymph node metastasis
  2. asingle factor analysis of clinical pathological characteristics and disease-free survival
  3. bmultifactor analysis of clinical pathological characteristics and disease-free survival
  4. csingle factor analysis of clinical pathological characteristics and overall survival
  5. dmultifactor analysis of clinical pathological characteristics and overall survival